Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shibo, Hillyer, Christopher, Du, Lanying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129017/
https://www.ncbi.nlm.nih.gov/pubmed/32249063
http://dx.doi.org/10.1016/j.it.2020.03.007
_version_ 1783516693446787072
author Jiang, Shibo
Hillyer, Christopher
Du, Lanying
author_facet Jiang, Shibo
Hillyer, Christopher
Du, Lanying
author_sort Jiang, Shibo
collection PubMed
description Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
format Online
Article
Text
id pubmed-7129017
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71290172020-04-08 Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses Jiang, Shibo Hillyer, Christopher Du, Lanying Trends Immunol Article Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs. The Author(s). Published by Elsevier Ltd. 2020-05 2020-04-02 /pmc/articles/PMC7129017/ /pubmed/32249063 http://dx.doi.org/10.1016/j.it.2020.03.007 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jiang, Shibo
Hillyer, Christopher
Du, Lanying
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
title Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
title_full Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
title_fullStr Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
title_full_unstemmed Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
title_short Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
title_sort neutralizing antibodies against sars-cov-2 and other human coronaviruses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129017/
https://www.ncbi.nlm.nih.gov/pubmed/32249063
http://dx.doi.org/10.1016/j.it.2020.03.007
work_keys_str_mv AT jiangshibo neutralizingantibodiesagainstsarscov2andotherhumancoronaviruses
AT hillyerchristopher neutralizingantibodiesagainstsarscov2andotherhumancoronaviruses
AT dulanying neutralizingantibodiesagainstsarscov2andotherhumancoronaviruses

Ejemplares similares